Skip to main content
. 2018 Jun 4;215(6):1679–1692. doi: 10.1084/jem.20172048

Figure 4.

Figure 4.

ZA is a direct inhibitor of UGT8 and inhibits breast cancer cell migration and invasion. (A and B) Expression of GalCer and sulfatide was measured by immunofluorescent staining in MDA-MB231 and SUM159 cells treated with or without ZA (20 µM; A), HCC1937 cells with empty vector, or stable UGT8 expression as well as UGT8-expressing HCC1937 cells treated with or without ZA (20 µM; B). Nuclei were visualized with DAPI (blue). Bars, 20 µm. (C) In vitro activity assay of UGT8 was performed by mixing UDP-galactose, substrate, and lysate of MDA-MB231 cells. After treatment of the indicated concentration of ZA, UDP-galactose consumption and UDP production were tested by HPLC system. The percentage of UDP-galactose consumption and UDP production was shown in the bar graph (mean ± SD in three separate experiments). (D) Expression of GalCer and sulfatide was examined by immunoblotting in MDA-MB231 and SUM159 cells treated with the indicated concentration of ZA. (E and F) Migratory ability (E) and invasiveness (F) of MDA-MB231 and SUM159 cells treated with the indicated concentration of ZA. The percentage of migratory and invasive cells was shown in the bar graph (mean ± SD in three separate experiments). *, P < 0.05 by Student’s t test.